The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Alosetron-Global Market Insights and Sales Trends 2025
Synopsis
Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.
The global Alosetron market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alosetron in various end use industries. The expanding demands from the Hospital and Drugstore, are propelling Alosetron market. 0.5 mg Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1 mg Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Alosetron market, driven by demand from China, the second largest economy with some signs of stabilising, the Alosetron market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alosetron, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alosetron market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alosetron market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alosetron sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alosetron covered in this report include Sebela Pharmaceuticals, Amneal, Par Pharmaceutical and West-Ward Pharmaceuticals, etc.
The global Alosetron market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sebela Pharmaceuticals
Amneal
Par Pharmaceutical
West-Ward Pharmaceuticals
Global Alosetron market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alosetron market, Segment by Type:
0.5 mg Tablets
1 mg Tablets
Global Alosetron market, by Application
Hospital
Drugstore
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alosetron manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alosetron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.
The global Alosetron market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alosetron in various end use industries. The expanding demands from the Hospital and Drugstore, are propelling Alosetron market. 0.5 mg Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 1 mg Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Alosetron market, driven by demand from China, the second largest economy with some signs of stabilising, the Alosetron market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alosetron, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alosetron market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alosetron market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alosetron sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alosetron covered in this report include Sebela Pharmaceuticals, Amneal, Par Pharmaceutical and West-Ward Pharmaceuticals, etc.
The global Alosetron market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sebela Pharmaceuticals
Amneal
Par Pharmaceutical
West-Ward Pharmaceuticals
Global Alosetron market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alosetron market, Segment by Type:
0.5 mg Tablets
1 mg Tablets
Global Alosetron market, by Application
Hospital
Drugstore
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alosetron manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alosetron in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Alosetron Market Overview
1.1 Alosetron Product Overview
1.2 Alosetron Market Segment by Type
1.2.1 0.5 mg Tablets
1.2.2 1 mg Tablets
1.3 Global Alosetron Market Size by Type
1.3.1 Global Alosetron Market Size Overview by Type (2018-2029)
1.3.2 Global Alosetron Historic Market Size Review by Type (2018-2023)
1.3.3 Global Alosetron Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Alosetron Sales Breakdown by Type (2018-2023)
1.4.2 Europe Alosetron Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Alosetron Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Alosetron Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Alosetron Sales Breakdown by Type (2018-2023)
2 Global Alosetron Market Competition by Company
2.1 Global Top Players by Alosetron Sales (2018-2023)
2.2 Global Top Players by Alosetron Revenue (2018-2023)
2.3 Global Top Players by Alosetron Price (2018-2023)
2.4 Global Top Manufacturers Alosetron Manufacturing Base Distribution, Sales Area, Product Type
2.5 Alosetron Market Competitive Situation and Trends
2.5.1 Alosetron Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Alosetron Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alosetron as of 2022)
2.7 Date of Key Manufacturers Enter into Alosetron Market
2.8 Key Manufacturers Alosetron Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Alosetron Status and Outlook by Region
3.1 Global Alosetron Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Alosetron Historic Market Size by Region
3.2.1 Global Alosetron Sales in Volume by Region (2018-2023)
3.2.2 Global Alosetron Sales in Value by Region (2018-2023)
3.2.3 Global Alosetron Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Alosetron Forecasted Market Size by Region
3.3.1 Global Alosetron Sales in Volume by Region (2024-2029)
3.3.2 Global Alosetron Sales in Value by Region (2024-2029)
3.3.3 Global Alosetron Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Alosetron by Application
4.1 Alosetron Market Segment by Application
4.1.1 Hospital
4.1.2 Drugstore
4.2 Global Alosetron Market Size by Application
4.2.1 Global Alosetron Market Size Overview by Application (2018-2029)
4.2.2 Global Alosetron Historic Market Size Review by Application (2018-2023)
4.2.3 Global Alosetron Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Alosetron Sales Breakdown by Application (2018-2023)
4.3.2 Europe Alosetron Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Alosetron Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Alosetron Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Alosetron Sales Breakdown by Application (2018-2023)
5 North America Alosetron by Country
5.1 North America Alosetron Historic Market Size by Country
5.1.1 North America Alosetron Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Alosetron Sales in Volume by Country (2018-2023)
5.1.3 North America Alosetron Sales in Value by Country (2018-2023)
5.2 North America Alosetron Forecasted Market Size by Country
5.2.1 North America Alosetron Sales in Volume by Country (2024-2029)
5.2.2 North America Alosetron Sales in Value by Country (2024-2029)
6 Europe Alosetron by Country
6.1 Europe Alosetron Historic Market Size by Country
6.1.1 Europe Alosetron Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Alosetron Sales in Volume by Country (2018-2023)
6.1.3 Europe Alosetron Sales in Value by Country (2018-2023)
6.2 Europe Alosetron Forecasted Market Size by Country
6.2.1 Europe Alosetron Sales in Volume by Country (2024-2029)
6.2.2 Europe Alosetron Sales in Value by Country (2024-2029)
7 Asia-Pacific Alosetron by Region
7.1 Asia-Pacific Alosetron Historic Market Size by Region
7.1.1 Asia-Pacific Alosetron Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Alosetron Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Alosetron Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Alosetron Forecasted Market Size by Region
7.2.1 Asia-Pacific Alosetron Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Alosetron Sales in Value by Region (2024-2029)
8 Latin America Alosetron by Country
8.1 Latin America Alosetron Historic Market Size by Country
8.1.1 Latin America Alosetron Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Alosetron Sales in Volume by Country (2018-2023)
8.1.3 Latin America Alosetron Sales in Value by Country (2018-2023)
8.2 Latin America Alosetron Forecasted Market Size by Country
8.2.1 Latin America Alosetron Sales in Volume by Country (2024-2029)
8.2.2 Latin America Alosetron Sales in Value by Country (2024-2029)
9 Middle East and Africa Alosetron by Country
9.1 Middle East and Africa Alosetron Historic Market Size by Country
9.1.1 Middle East and Africa Alosetron Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Alosetron Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Alosetron Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Alosetron Forecasted Market Size by Country
9.2.1 Middle East and Africa Alosetron Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Alosetron Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sebela Pharmaceuticals
10.1.1 Sebela Pharmaceuticals Company Information
10.1.2 Sebela Pharmaceuticals Introduction and Business Overview
10.1.3 Sebela Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sebela Pharmaceuticals Alosetron Products Offered
10.1.5 Sebela Pharmaceuticals Recent Development
10.2 Amneal
10.2.1 Amneal Company Information
10.2.2 Amneal Introduction and Business Overview
10.2.3 Amneal Alosetron Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amneal Alosetron Products Offered
10.2.5 Amneal Recent Development
10.3 Par Pharmaceutical
10.3.1 Par Pharmaceutical Company Information
10.3.2 Par Pharmaceutical Introduction and Business Overview
10.3.3 Par Pharmaceutical Alosetron Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Par Pharmaceutical Alosetron Products Offered
10.3.5 Par Pharmaceutical Recent Development
10.4 West-Ward Pharmaceuticals
10.4.1 West-Ward Pharmaceuticals Company Information
10.4.2 West-Ward Pharmaceuticals Introduction and Business Overview
10.4.3 West-Ward Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2018-2023)
10.4.4 West-Ward Pharmaceuticals Alosetron Products Offered
10.4.5 West-Ward Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Alosetron Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Alosetron Industrial Chain Analysis
11.4 Alosetron Market Dynamics
11.4.1 Alosetron Industry Trends
11.4.2 Alosetron Market Drivers
11.4.3 Alosetron Market Challenges
11.4.4 Alosetron Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Alosetron Distributors
12.3 Alosetron Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
